Clozapine-Induced Gastrointestinal Hypomotility: A 22-Year Bi-National Pharmacovigilance Study of Serious or Fatal ‘Slow Gut’ Reactions, and Comparison with International Drug Safety Advice

INTRODUCTION: Clozapine is the preferred antipsychotic for treatment-resistant schizophrenia, but has significant adverse effects, including gastrointestinal hypomotility or ‘slow gut’, which may result in severe constipation, ileus, bowel obstruction, and even death. These gastrointestinal effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Every-Palmer, Susanna, Ellis, Pete M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533872/
https://www.ncbi.nlm.nih.gov/pubmed/28623627
http://dx.doi.org/10.1007/s40263-017-0448-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533872/
https://www.ncbi.nlm.nih.gov/pubmed/28623627
http://dx.doi.org/10.1007/s40263-017-0448-6

Ejemplares similares